The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
This prospective randomised controlled trial was designed to assess the effectiveness of the Bispectral Index Sedation (BIS) monitor in supporting clinical, sedation management decisions in mechanically ventilated ICU patients. The primary hypothesis for the study is that patients with Bispectral Index Sedation (BIS) monitoring will receive less sedation then those receiving standard sedation management. The secondary hypotheses are:
- 1.Patients with BIS have fewer ventilation days than those receiving standard sedation management.
- 2.Level of sedation administered will differ according to the critical care experience and qualification of the nurse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2004
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
November 28, 2013
CompletedNovember 28, 2013
November 1, 2013
9 months
September 9, 2005
November 25, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Optimised sedation management for patients through the use of BIS monitoring.
Secondary Outcomes (2)
Reduction in mechanical ventilation time.
Reduced length of stay in the intensive care unit.
Interventions
Eligibility Criteria
You may qualify if:
- Intubated and ventilated for at least 24 hours
- Sedated on morphine and midazelam infusions
You may not qualify if:
- Intracranial injury
- Status epilepticus
- Facial Burns
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayside Healthlead
Study Sites (1)
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy A Weatherburn
The Alfred
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2005
First Posted
November 28, 2013
Study Start
September 1, 2004
Primary Completion
June 1, 2005
Study Completion
July 1, 2005
Last Updated
November 28, 2013
Record last verified: 2013-11